StockNews.AI
ORCL
StockNews.AI
7 hrs

Oracle Enhances Electronic Data Capture Solution to Streamline Clinical Trials and Help Bring New Therapies to Market Faster

1. Oracle enhances Clinical One Data Collection with AI-driven EHR interoperability. 2. New features improve data collection and safety reporting for clinical trials. 3. Integration with safety solutions streamlines adverse event management. 4. AI advancements aim for faster and more accurate clinical workflows. 5. Updates enhance compliance and operational efficiency in clinical research.

8m saved
Insight
Article

FAQ

Why Bullish?

The advancements will likely increase Oracle's market share in healthcare solutions, similar to past successful product launches that boosted revenues.

How important is it?

The article reinforces Oracle's competitive edge in healthcare technology, potentially driving future revenue growth.

Why Long Term?

These improvements position Oracle favorably in a growing market, anticipating increased adoption over several years.

Related Companies

AVLRMSFTIBMVMW
Updates include AI-enabled EHR interoperability, comprehensive data collection, and safety integration capabilities , /PRNewswire/ -- Oracle today introduced significant advancements to its Electronic Data Capture (EDC) solution, Oracle Clinical One Data Collection. These new capabilities enable seamless interoperability with Electronic Health Record (EHR) systems, enhance data collection capabilities at trial sites, and provide end-to-end integration with Oracle Safety One Argus and other safety solutions. These updates are designed to simplify clinical workflows and eliminate data friction across systems to help accelerate research, improve safety reporting, and bring therapies to market faster. These advancements, developed in collaboration with pharma industry leaders and Oracle's CRO Growth Network collaborators, reflect Oracle's commitment to delivering AI-driven, interoperable solutions that enhance automation, streamline data connectivity, and offer customers greater choice and flexibility. "In today's complex clinical trial landscape, interoperability and streamlined data flow are paramount," said Deepu Joseph, Global Head of DM, Country Head India, Excelya. "Oracle's focus on agnostic EHR-EDC integration and complete safety reporting within Clinical One Data Collection increases operational efficiency for sites and sponsors. This kind of robust, connected ecosystem is exactly what the industry needs, to reduce burden and accelerate studies." Comprehensive EHR integrationFurthering Oracle's mission to deliver a connected and intelligent clinical research ecosystem, the new EDC enhancements enable researchers to use the AI-enabled Oracle Clinical Connector to securely transfer data between Oracle Health and other EHRs and Oracle Clinical One Data Collection. This integration removes manual busywork by enabling direct, EHR data transfers that can help improve accuracy and speed research. Site and subject-level data and document managementWhile structured data captured through eCRFs is essential, modern clinical research also requires the flexibility to collect and manage other types of data. The new release increases document management capabilities for clinical sites with site-level data collection to support all file formats at the subject level, allowing documents to be uploaded alongside structured data within the EDC system. For example, site staff can use a mobile device to upload contextual data directly into the platform, such as a subject's scanned lab result. This helps teams keep documentation centralized, supports a more complete view of the subject, and accelerates research workflows. Integration with safety solutionsReporting serious adverse events often requires duplicative effort across disconnected systems, which can slow research, is prone to inaccurate entries, and risks quality. Clinical One Data Collection now offers integrated safety capabilities across the workflow for faster and more accurate adverse event management. The safety integration uses the ICH E2B(R3) standard, enabling sites to more quickly and seamlessly address their regulatory compliance obligations to immediately report the occurrence of serious adverse events (SAE) to the trial sponsor. The integration is fully interoperable with Oracle Safety One Argus and other safety solutions, giving customers choice and flexibility, while helping to maintain compliance and efficiency across the clinical development lifecycle. "Our EDC enhancements underscore Oracle's commitment to delivering AI-driven capabilities and aligning clinical research and clinical care by creating a more open healthcare ecosystem that fuels medical breakthroughs for the patients who desperately need them," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "These innovations in data collection and safety can help further streamline drug development, to help improve data integrity and regulatory adherence, while empowering researchers to conduct trials with efficiency and precision." The new features and enhancements within Oracle Clinical One Data Collection are available to customers globally as part of their standard clinical update process. To learn more about how Oracle is transforming clinical trials with innovative solutions designed to unify data from clinical trials, streamline and automate safety case management, generate real-world evidence from unique data sets, and guide brand strategy with commercial insights visit https://www.oracle.com/life-sciences/ or join us at the Oracle Health and Life Sciences Summit in Orlando, September 9-11, 2025, to see the solutions in action. Register now at: https://www.oracle.com/health/health-life-sciences-summit/. About Oracle Life SciencesOracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements, empowering the Life Sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences. About OracleOracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com. TrademarksOracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing. SOURCE Oracle WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News